E-DRUG: Drug Prices lower thanks to price controls (2)
------------------------------------------------------
Hi
Since long the wish to ensure affordability, availability and accessibility to essential medicines in the country has been cherished.
Let us hope that the move of Indian Government to bring essential medicines under price control will provide the expected results in making them affordable.
If only this is achieved then we look forward to more positivism in improvement of the availability and accessibility of these affordable essential medicines.
Dr Vijay Thawani,
Nagpur,
India
vijaythawani@rediffmail.com
Dr Vijay Thawani,
14-A, Jeevan Jyoti, Clarke Town,
Nagpur-440 004, India.
Associate Professor in Pharmacology,
Govt. Medical College, Nagpur-440 003, India.
Net group: http://health.groups.yahoo.com/group/netrum
URL: vijaythawani@blogspot.com
Land line:(Res)+91-0712-2522977
Cell: +91-9372302436
E-DRUG: Drug Prices lower thanks to price controls (3)
------------------------------------
Respected members
There are many devloping countries who wish to copy the model of the great
USA. One exception is Bangladesh. No LDC or DC is in a position to fight
USA drug cartels.
Healthcare is the only business to be wrong line business ,if profit is the
sole goal. The great WHO should insist on all governments that all essential
drugs be under price control by the governments all the times.
Many countries in the world do not know MRP: maximum retail price of a drug)
or MAPE(maximum allowable post manufacturing expenses). By keeping MAPE at
100% we in India still achieved the distinction of the largest formulating
capacity in world.
We look fwd to eminent organisations like FIP or WHO to play a steallar
role in ensuring all essential drugs are affordble to genaral public.
Regards
V.Bhava Narayana
Editor
Pharmed Trade News
3-3-62/A,New Gokhale Nagar,
Ramanthapur,Hyderabad-500 013.
Phone :91-40-27030681,32995727
Mob 919849551183,919323131524
Mobile:91-98495-51183
www.pharmedtradenews.com
Successful Medical Practice-300 page book -Ideal gift to Doctors
j
E-DRUG: Drug Prices lower thanks to price controls (4)
-----------------------------------------
"Price Controls" Capturing the language
How interesting that long patents, data exclusivity, or other forms of
protection from normal price competition are usually not discussed as forms
of "price controls." The term is also applied only to governmental control
of prices, not to corporate control of prices. A more balanced use of
language would point out that in countries like the USA, payers are
subjected to corporate price controls, including the increase in prices of
patented drugs each year they are in the market; while in countries like
Germany, producers are subjected to government price controls (that tend to
be considerably steadier once they are set).
Neoclassical theory holds that prices are set by the market; so exemptions
from market price competition allow sellers to set and control their prices.
Patent length, then, is a license to control prices, to the extent that the
patent-holder can. Thus increasing patent length to 25 years would
constitute greater corporate price control, and decreasing patent length to
15 years would constitute less corporate price control than at present.
Don Light
Donald W. Light
tel: 1-609-915-1588
fax: 1-609-924-1830
dlight@Princeton.EDU
[Thanks Don! KM, moderator]